OXFORD, Ohio and COCONUT CREEK, Fla., April 12, 2021 /CNW/ — PsyBio Therapeutics Corp. (TSXV: PSYB) (“PsyBio” or the “Company“), a biotechnology company pioneering the next generation of targeted psychoactive medications, is pleased to announce that it has submitted an application to have its subordinate voting shares (the “Shares”) listed for trading on the OTCQX® Best Market (the “OTCQX“)…


Previous articleAwakn launches Digital unit and signs agreement with the University of Exeter
Next articlePT239 – Richie Ogulnick – Ibogaine, Unicity, and Beneficence